BioCardia Inc. (BCDAW)
0.01
0.00 (58.73%)
At close: Aug 02, 2024, 8:00 PM
58.73% (1D)
| Bid | n/a |
| Market Cap | 10.12K |
| Revenue (ttm) | 58K |
| Net Income (ttm) | -7.95M |
| EPS (ttm) | -3.2 |
| PE Ratio (ttm) | -0.00190625 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | n/a |
| Volume | 18,712 |
| Avg. Volume (20D) | 0 |
| Open | 0.01 |
| Previous Close | 0.01 |
| Day's Range | 0.01 - 0.01 |
| 52-Week Range | 0.01 - 0.01 |
| Beta | 1.36 |
About BCDAW
BioCardia, Inc., a clinical-stage regenerative medicine company, engages in development of cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. Its lead therapeutic candidate is the CardiAMP, an autologous mononuclear cell therapy system for the treatment of heart failure and chronic myocardial ischemia; and allogeneic cell therapy for cardiac and pulmonary disease. The company is also developing allogeneic cells ther...
Industry Biotechnology
Sector Healthcare
IPO Date Aug 2, 2019
Employees 16
Stock Exchange NASDAQ
Ticker Symbol BCDAW
Website https://www.biocardia.com